Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansell

Showing results (171-180 of 2,414) with videos related to

Pageof 242
Sort By:
Bioseparation|January 29, 2003
MIP-ligand binding assays (pseudo-immunoassays)R J Ansell
Virginia Medical Monthly|May 11, 1975
The effectiveness of 5-fluorouracil administered orallyB F Ansell
The Lancet. Oncology|June 9, 2012
Beyond targeting malignant B cellsStephen M Ansell
Current Atherosclerosis Reports|December 21, 2000
Cholesterol, stroke risk, and stroke preventionB J Ansell
The Journal of the American Osteopathic Association|September 29, 2001
Managing borderline levels of risk for coronary heart disease: two illustrative case presentationsB J Ansell
Archives of Internal Medicine|August 3, 2001
Appropriate first-line lipid-lowering therapy for type 1 diabetes mellitusB J Ansell
Cancer Discovery|November 3, 2019
Immunotransplant: Preventing Unintended ConsequencesStephen M Ansell
Journal of the Royal College of Physicians of London|January 23, 2019
Still's DiseaseBarbara M Ansell
Leukemia & Lymphoma|January 12, 2019
Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?Stephen M Ansell
Proceedings of the Royal Society of Medicine|September 1, 1975
Rheumatoid arthritis followed by systemic lupus erythematosusB M Ansell
Pageof 242

Showing results (171-180 of 2,414) with videos related to

Sort By:
Pageof 242
Bioseparation|January 29, 2003
MIP-ligand binding assays (pseudo-immunoassays)R J Ansell
Virginia Medical Monthly|May 11, 1975
The effectiveness of 5-fluorouracil administered orallyB F Ansell
The Lancet. Oncology|June 9, 2012
Beyond targeting malignant B cellsStephen M Ansell
Current Atherosclerosis Reports|December 21, 2000
Cholesterol, stroke risk, and stroke preventionB J Ansell
The Journal of the American Osteopathic Association|September 29, 2001
Managing borderline levels of risk for coronary heart disease: two illustrative case presentationsB J Ansell
Archives of Internal Medicine|August 3, 2001
Appropriate first-line lipid-lowering therapy for type 1 diabetes mellitusB J Ansell
Cancer Discovery|November 3, 2019
Immunotransplant: Preventing Unintended ConsequencesStephen M Ansell
Journal of the Royal College of Physicians of London|January 23, 2019
Still's DiseaseBarbara M Ansell
Leukemia & Lymphoma|January 12, 2019
Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?Stephen M Ansell
Proceedings of the Royal Society of Medicine|September 1, 1975
Rheumatoid arthritis followed by systemic lupus erythematosusB M Ansell
Pageof 242